Literature DB >> 9505189

Interleukin-2, interleukin-15, and their receptors.

T Waldmann1, Y Tagaya, R Bamford.   

Abstract

Both IL-15 and IL-2 are 14-15 kDa members of the four alpha-helical bundle family of cytokines that have T cell growth factor activity. In contrast to the pattern manifested by IL-2, IL-15 mRNA is produced by a wide variety of tissues other than T cells. We have demonstrated that IL-15 expression is posttranscriptionally regulated by multiple elements, including the ten upstream AUGs of the 5' UTR, a 48aa signal peptide and the carboxy-terminus of the mature protein. IL-15 utilizes two distinct receptor signaling pathways. In T cells the IL-15 receptor includes IL-2R beta and gamma c subunits shared with IL-2 as well as an IL-15 specific receptor, IL-15R alpha. However, mast cells respond to IL-15 using a receptor system that does not share elements with the IL-2R system but involves a novel 60-65 kDa IL-15RX subunit. In mast cells, IL-15 signaling involves JAK-2 and STAT-5 activation rather than the JAK-1 and JAK-3 as well as the STAT-3 and STAT-5 used by both IL-2 and IL-15 in activated T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9505189     DOI: 10.3109/08830189809042995

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  41 in total

1.  IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients.

Authors:  N Azimi; M Nagai; S Jacobson; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes.

Authors:  N Manjunath; P Shankar; J Wan; W Weninger; M A Crowley; K Hieshima; T A Springer; X Fan; H Shen; J Lieberman; U H von Andrian
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Multicytokine detection improves latent tuberculosis diagnosis in health care workers.

Authors:  Pierre-Alain Rubbo; Nicolas Nagot; Vincent Le Moing; Marylène Brabet; Arnaud Bourdin; Erika Nogué; Karine Bolloré; Jean-Pierre Vendrell; Philippe Van De Perre; Edouard Tuaillon
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

4.  Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.

Authors:  Jianping Huang; Keith W Kerstann; Mojgan Ahmadzadeh; Yong F Li; Mona El-Gamil; Steven A Rosenberg; Paul F Robbins
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

5.  Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.

Authors:  Bibiana Bielekova; Marta Catalfamo; Susan Reichert-Scrivner; Amy Packer; Magdalena Cerna; Thomas A Waldmann; Henry McFarland; Pierre A Henkart; Roland Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

6.  Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models.

Authors:  Peter R Rhode; Jack O Egan; Wenxin Xu; Hao Hong; Gabriela M Webb; Xiaoyue Chen; Bai Liu; Xiaoyun Zhu; Jinghai Wen; Lijing You; Lin Kong; Ana C Edwards; Kaiping Han; Sixiang Shi; Sarah Alter; Jonah B Sacha; Emily K Jeng; Weibo Cai; Hing C Wong
Journal:  Cancer Immunol Res       Date:  2015-10-28       Impact factor: 11.151

Review 7.  Role of IL-2 in cancer immunotherapy.

Authors:  Tao Jiang; Caicun Zhou; Shengxiang Ren
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

8.  IL-15 receptor deletion results in circadian changes of locomotor and metabolic activity.

Authors:  Yi He; Xiaojun Wu; Reas S Khan; Abba J Kastin; Germaine G Cornelissen-Guillaume; Hung Hsuchou; Barry Robert; Franz Halberg; Weihong Pan
Journal:  J Mol Neurosci       Date:  2009-12-10       Impact factor: 3.444

9.  Modulation of interleukin-15-induced suppression of human neutrophil apoptosis by TNFalpha.

Authors:  Xiuping Liu; Changyun Xiong; Chunhong Li; Deguang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

Review 10.  Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis.

Authors:  Iain B McInnes; J Alastair Gracie
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.